Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>Events>This Event
  Events - April 2013

Nanomedicine 2013

11 Apr 2013 - 12 Apr 2013 - Barcelona, Spain

Bookmark and Share

Market researchers have estimated that the Nanomedicine industry was worth over $72.8billion in 2011 and is expected to grow rapidly to the level of influencing entire economies. Due to major advances in science and engineering, the relatively young field of nanotechnology has been expanding significantly. Despite the exciting advancements in this discipline, which involves miniscule manufactured products 1 – 100nm in size, the field of nanomedicine has yet to be exploited to its full potential. A large part of the nanomedicine industry is within the use of nanoparticles for the treatment of cancerous tumors. However, many nanoparticles show signs of toxicity in cells and this can be caused by the inherent properties, size and surface charge of the particles. This leaves the door open for engineered solutions to enable nanomedicine to continue progressing at its historic rate.

This conference will aim to provide a multidisciplinary approach to tackle the fundamental challenges in this speciality, innovative strategies for testing exposure, and techniques for improving the reliability and accuracy of results.

The conference will be co-located with our ADME & PT meeting. Registered delegates will have unrestricited access to both meetings ensuring a comprehensive learning and sharing experience as well as being financially beneficial for attendees.

Further information
Scientific News
Integrated Omics Analysis
Studying multi-omics promises to give a more holistic picture of the organism and its place in its ecosystem, however despite the complexities involved those within the field are optimistic.
Unravelling the Role of Key Genes and DNA Methylation in Blood Cell Malignancies
Researchers from the University of Nebraska Medical Center have demonstrated the role of Dnmt3a in safeguarding normal haematopoiesis.
Salford Lung Study - The First Real World Clinical Trial
In this podcast, we learn about the Salford Lung Study and its potential to revolutionize the way we assess new drugs and treatments around the world.
Point of Care Diagnostics - A Cautious Revolution
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.
Gene Therapy Going Global with Portable Device
Portable 'gene therapy in a box' could make future cancer and HIV cures affordable in developing countries.
Preventing "Friendly Fire" in the Pancreas
Researchers inhibit process that leads to the body attacking its own insulin-producing cells.
3D-Printed Heart-On-A-Chip with Integrated Sensors
Researchers have created the first 3D-printed organ-on-a-chip with integrated sensors, paving the way for more complex, customizable devices.
Wrapping up the Genome
Researchers successfully package complete yeast genome using purified components, yielding new insights into genome mechanisms.
Drug Target for Triple-Negative Breast Cancer Found
A team of researchers led by UC San Francisco scientists has identified a new drug target for triple-negative breast cancer.
Precision Medicine Guiding Cancer Patients’ Chemotherapy Decision
New study finds doctors use genetic test to measure breast cancer recurrence risk, make tailored treatment recommendations.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,200+ scientific videos